FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $488 | +48700.0% | 65 | -11.0% | 0.00% | – |
| Q2 2023 | $1 | -99.5% | 73 | -99.7% | 0.00% | – |
| Q1 2023 | $204 | – | 25,400 | +41539.3% | 0.00% | – |
| Q2 2022 | $0 | – | 61 | -14.1% | 0.00% | – |
| Q1 2022 | $0 | – | 71 | +31.5% | 0.00% | – |
| Q4 2021 | $0 | – | 54 | +134.8% | 0.00% | – |
| Q3 2021 | $0 | – | 23 | -58.2% | 0.00% | – |
| Q2 2021 | $0 | – | 55 | +266.7% | 0.00% | – |
| Q1 2021 | $0 | – | 15 | -80.8% | 0.00% | – |
| Q3 2020 | $0 | – | 78 | +239.1% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 23 | -93.3% | 0.00% | – |
| Q4 2019 | $2,000 | – | 342 | +159.1% | 0.00% | – |
| Q3 2019 | $0 | – | 132 | -10.8% | 0.00% | – |
| Q2 2019 | $0 | – | 148 | +410.3% | 0.00% | – |
| Q1 2019 | $0 | – | 29 | +141.7% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 12 | -84.4% | 0.00% | – |
| Q3 2018 | $1,000 | – | 77 | +234.8% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 23 | -59.6% | 0.00% | – |
| Q4 2017 | $1,000 | – | 57 | +850.0% | 0.00% | – |
| Q3 2017 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |